Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis

Journal of Cellular Physiology

Volumn 228, Issue 1, 2013, Pages 235-241

  Ricci, Alberto ^a,b   Cherubini, Emanuela ^a,b   Ulivieri, Alessandra ^b   Lavra, Luca ^b   Sciacchitano, Salvatore ^a,b   Scozzi, Davide ^a   Mancini, Rita ^a   Ciliberto, Gennaro ^c,d   Bartolazzi, Armando ^a   Bruno, Pierdonato ^a   Graziano, Paolo ^e   Mariotta, Salvatore ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN INTERACTING PROTEIN KINASE 2;

ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG FIBROBLAST; MICROSATELLITE MARKER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL LINE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LOSS OF HETEROZYGOSITY; LUNG; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES;

EID: 84867183297     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24129     Document Type: Article

References (42)

1. American Thoracic Society/European Respiratory Society. 2002. International multidisciplinary consensus classification of idiopathic interstitial pneumonias: General principles and recommendations. Am J Respir Crit Care Med 165: 277-304.
2. An Official ATS/ERS/JRS/ALAT Statement. 2011. Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
3. Barili P, Bronzetti E, Ricci A, Zaccheo D, Amenta F. 2002. Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex. Brain Res 854: 130-138.
4. Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J. 2005. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870.
5. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Ørntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. 2006. Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
6. Calzado MA, Renner F, Roscic A, Schmitz ML. 2007. HIPK2: A versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 6: 139-143.
7. Calzado MA, De La Vega L, Munoz E, Schmitz ML. 2009. From top to bottom: The two faces of HIPK2 for regulation of the hypoxic response. Cell Cycle 8: 1659-1664.
8. Cecchinelli B, Lavra L, Rinaldo C, Iacovelli S, Gurtner A, Gasbarri A, Ulivieri A, Del Prete F, Trovato M, Piaggio G, Bartolazzi A, Soddu S, Sciacchitano S. 2006. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 26: 4746-4757.
9. Chilosi M, Poletti V, Murer B, Lestani M, Cancellieri A, Montagna L, Piccoli P, Cangi G, Semenzato G, Doglioni C. 2002. Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: The role of ΔN-p63. Lab Invest 82: 1335-1345.
10. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F. 2006. Oncogene induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
11. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M, Appella E, Soddu S. 2002. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4: 11-19.
12. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nat Protoc 1: 15-19.
13. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. 1998. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 78: 687-698.
14. Hofmann TG, Möller A, Sirma H, Zentgraf H, Taya Y, Dröge W, Will H, Schmitz ML. 2002. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4: 1-10.
15. Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtsuki Y, Yamaji Y, Takahara J. 1998. Overexpression of p53 protein in interstitial lung diseases. Respir Med 92: 184-190.
16. Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, Mazloom AR, Chen EY, D'Agati V, Xiong H, Ross MJ, Chen N, Ma'ayan A, He JC. 2012. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med 18: 580-588.
17. Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y. 1998. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 273: 25875-25879.
18. Kim YH, Choi CY, Kim Y. 1999. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc Natl Acad Sci USA 96: 12350-12355.
19. Kim EJ, Park JS, Um SJ. 2002. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem 277: 32020-32028.
20. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. 2002. A high-resolution recombination map of the human genome. Nat Genet 31: 241-247.
21. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. 2002. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166: 382-385.
22. Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N. 1999. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 20: 53-60.
23. Kuwano N, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, Kaneko Y, Matsuba T, Maeyama T, Hara N. 2000. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fbrosis in mice J Pathol 190: 221-229.
24. Kuwano K, Hagimoto N, Maeyama T, Fujita M, Yoshimi M, Inoshima I, Nakashima N, Hamada N, Watanabe K, Hara N. 2002. Mitochondria mediated apoptosis of lung epithelial cells in idiopatic interstitial pneumonias. Lab Invest 82: 1695-1706.
25. Maeyama T, Kuwano K, Kawasaki M, Kunitake R, Hagimoto N, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N. 2001. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur Respir J 17: 180-189.
26. Marshall RP, McAnulty RJ, Laurent GJ. 1997. The pathogenesis of pulmonary fibrosis: Is there a fibrosis gene?. Int J Biochem Cell Biol 29: 107-120.
27. Matute-Bello G, Liles WC, Radella F, II, Steinberg KP, Ruzinski JT, Jonas M, Chi EY, Hudson LD, Martin TR. 1997. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 156: 1969-1977.
28. Miki H, Mio T, Nagai S, Hoshino Y, Nagao T, Kitaichi M, Izumi T. 2000. Fibroblast contractility: Usual interstitial pneumonia and nonspecific interstitial pneumonia. Am J Respir Crit Care Med 162: 2259-2264.
29. Puca R, Nardinocchi L, Pistritto G, D'Orazi G. 2008. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol 109: 403-410.
30. Raghu G, Chen YY, Rusch V, Rabinovitch PS. 1998. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis 138: 703-708.
31. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A. 2001. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24: 591-598.
32. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghaven S, Bishop AE, Romanska HM, Pantelidis P, Black CM, Du Bois RM. 2003. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 167: 438-443.
33. Ricci A, Graziano P, Mariotta S, Cardillo G, Sposato B, Terzano C, Bronzetti E. 2005. Neurotrophin system expression in human pulmonary carcinoid tumors. Growth Factors 23: 303-312.
34. Rinaldo C, Prodosmo A, Siepi F, Soddu S. 2007. HIPK2: A multitalented partner for transcription factors in DNA damage response and development. Biochem Cell Biol 85: 411-418.
35. Selman M, Pardo A. 2002. Idiopathic pulmonary fibrosis: An epithelial/fibroblastic cross-talk disorder. Respir Res 3: 3-12.
36. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776.
37. Takahashi T, Munakata M, Ohtsuka Y, Nisihara H, Nasuhara Y, Kamachi-Satoh A, Dosaka-Akita H, Homma Y, Kawakami Y. 2002. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis. Cancer 95: 624-633.
38. Trovato M, Ulivieri A, Dominici R, Ruggeri RM, Vitarelli E, Benvenga S, Barresi G, Trimarchi F, Brunetti E, Vecchione A, Andreoli M, Sciacchitano S. 2004. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: Analysis of 318 microdissected thyroid lesions. Endocr Relat Cancer 11: 365-376.
39. Trovato-Salinaro A, Trovato-Salinaro E, Failla M, Mastruzzo C, Tomaselli V, Gili E, Crimi N, Condorelli DF, Vancheri C. 2006. Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis. Respir Res 7: 122.
40. Vancheri C, Sortino MA, Tomaselli V, Mastruzzo C, Condorelli F, Bellistri G, Pistorio MP, Canonico PL, Crimi N. 2000. Different expression of TNF-alpha receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: Potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 22: 628-634.
41. Winkler MK, Fowlkes JL. 2002. Metalloproteinase and growth factor interactions: Do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 283: 1-11.
42. Zhao HW, Lu CL, Yu RJ, Hou XM. 1999. An increase in hyaluronan by lung fibroblasts: A biomarker for intensity and activity of interstitial pulmonary fibrosis? Respirology 4: 131-138.